American Heart Journal
Volume 154, Issue 1 , Pages 46-53 , July 2007

Effect of exercise training on ventricular function, dyssynchrony, resting myocardial perfusion, and clinical outcomes in patients with heart failure: A nuclear ancillary study of Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION); design and rationale

  • Daniel R. Bensimhon, MD

      Affiliations

    • Moses Cone Hospital, Greensboro, NC
    • ,
  • George L. Adams, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • David J. Whellan, MD, MHS

      Affiliations

    • Jefferson Medical College, Philadelphia, PA
    • ,
  • Robert A. Pagnanelli, BSRT, CNMT, NCT

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Mark Trimble, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Benjamin A. Lee, BA

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Kerry L. Lee, PhD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Stephen J. Ellis, PhD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • William E. Kraus, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • David S. Rendall, PA-C

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Ami E. Iskandrian, MD

      Affiliations

    • University of Alabama at Birmingham, Birmingham, AL
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Salvador Borges-Neto, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Salvador Borges-Neto, MD, Department of Radiology, Duke University Medical Center, Durham, NC 27710.
    • ,
  • on behalf of the HF-ACTION Trial Investigators

Received 11 August 2006 ,Accepted 28 March 2007.

References 

  1. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics—2006 update. Circulation. 2006;113:1–67
  2. Bulkley BH, Hutchins GM, Bailey I, et al. Thallium 201 imaging and gated cardiac blood pool scans in patients with ischemic and idiopathic congestive cardiomyopathy: a clinical and pathologic study. Circulation. 1977;55:753–760
  3. Dunn RF, Uren RF, Sadick N, et al. Comparison of thallium-201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Circulation. 1982;66:804–810
  4. Saltissi S, Hockings B, Croft DN, et al. Thallium-201 myocardial imaging in patients with dilated and ischaemic cardiomyopathy. Br Heart J. 1981;46:290–295
  5. Eichorn EJ, Kisinski EJ, Lewis SM, et al. Usefulness of dipyradimole-thallium 201 perfusion scanning for distinguishing ischemic from nonischemic cardiomyopathy. Am J Cardiol. 1988;62:945–951
  6. Tauberg SG, Orie JE, Bartlett BE, et al. Usefulness of thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy. Am J Cardiol. 1993;71:674–680
  7. Chikamori C, Yoshinori LD, Yonezawa Y, et al. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol. 1992;69:650–653
  8. Franchini M, Traversi E, Cannizzaro G, et al. Dobutamine stress echocardiography and thallium-201 SPECT for detecting ischaemic dilated cardiomyopathy in patients with heart failure. Eur J Echocardiography. 2000;1:109–115
  9. Danias PG, Ahlberg AW, Clark BA, et al. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol. 1998;82:1253–1258
  10. Iskandrian AS, Hakki AH, Kane S. Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction. Am Heart J. 1986;111:760–767
  11. Mody FV, Brunken RC, Stevenson LW, et al. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol. 1991;17:373–383
  12. Julliere Y, Marie PY, Danchin N, et al. Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. Eur Heart J. 1993;14:1163–1169
  13. Greenberg JM, Murphy JH, Okada RD, et al. Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: comparison of idiopathic dilated cardiomyopathy and coronary artery disease. Am J Cardiol. 1985;55:541–544
  14. Glamann DB, Lange RA, Corbett JR. Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. Arch Intern Med. 1992;152:769–772
  15. Bourque JM, Velazquez EJ, Borges-Neto S, et al. Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?. Am Heart J. 2003;145:758–767
  16. Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186–193
  17. Wallis DE, O'Connell JB, Henkin RE, et al. Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. J Am Coll Cardiol. 1984;4:674–679
  18. Dori YL, Chikamori T, Takata J, et al. Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;67:188–193
  19. Belardinelli R, Georgiou D, Ginzton L, et al. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation. 1998;97:553–561
  20. Gunning MG, Walker J, Eastick S, et al. Exercise training following myocardial infarction improves myocardial perfusion assessed by thallium-201 scintigraphy. Int J Cardiol. 2002;84:233–239
  21. Belardinelli R, Georgiou D, Cianci G, et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure. Circulation. 1999;99:1173–1182
  22. Hung J, Gordon EP, Houston N, et al. Changes in rest and exercise myocardial perfusion and left ventricular function 3 to 26 weeks after clinically uncomplicated acute myocardial infarction: effects of exercise training. Am J Cardiol. 1984;54:943–950
  23. Beller GA, Murray GC, ErkenBrack SK. Influence of exercise training soon after myocardial infarction on regional myocardial perfusion and resting left ventricular function. Clin Cardiol. 1992;15:17–23
  24. Whelan DJ, O'Connor CM, Lee KL, et al. Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION): design and rationale. Am Heart J. 2007;153:201–211
  25. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659–663
  26. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549–556
  27. Hachamovicth R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and impact on subsequent patient management. Circulation. 1996;93:905–914
  28. Hachamovicth R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535–543
  29. Borges-Neto S, Shaw LK, Alexander JH, et al. Incremental prognostic power of SPECT myocardial perfusion imaging in patients with known or suspected coronary artery disease. Am J Cardiol. 2005;95:182–188
  30. Uretsky BF, Thygesen K, Armstrong PW, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment with Lisinopril And Survival (ATLAS) Trial. Circulation. 2000;102:611–616
  31. Cleland JG, Armstrong P, Horowitz JD, et al. Baseline characteristics of patients recruited into the Assessment of Treatment with Lisinopril And Survival study. Eur J Heart Fail. 1999;1:73–79
  32. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol. 1987;60:1340–1355
  33. Felker GM, Shaw LK, O'Connor CM. A standard definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39:210–218
  34. Chen J, Garcia EV, Folks RD, et al. Onset of left ventricular contraction determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol. 2005;6:687–695
  35. Bleeker GB, Kaandorp TA, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113:969–976
  36. Cooke CD, Garcia EV, Cullom SJ, et al. Determining the accuracy of calculating systolic wall thickening using a fast Fourier transform approximation: a simulation study based on canine and patient data. J Nucl Med. 1994;35:1185–1192

 The HF-ACTION trial is funded by a grant (Coordinating Center, Dr Christopher O'Connor, PI: 5U01-HL063747-04; Economic and Quality of Life, Dr Kevin A. Schulman, PI: 5U01-HL066461-04) from the National Heart, Lung, and Blood Institute, Bethesda, MD, USA. The study was supported by an investigator-initiated grant from GE Health Care.

PII: S0002-8703(07)00273-6

doi: 10.1016/j.ahj.2007.03.045

American Heart Journal
Volume 154, Issue 1 , Pages 46-53 , July 2007

Article Tools

* Image Usage & Resolution